The Effect of Semaglutide on Cardiovascular Markers and Liver Function

Clinical trial NCT06301191 · UNKNOWN

Trial details

NCT number: NCT06301191
Sponsor: Attikon Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes Type 2

Start date: 2022-03-01
Primary completion: 2023-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.